Joseph M Brandwein

10PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 27, 2026
Controversies in the Management of AML in Older Patients: A Canadian Perspective.

|Jul 27, 2026
Management of Acute Myeloid Leukemia in Older Patients: An Updated Canadian Consensus.

|Oct 09, 2024
Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia Cells.

Jay M Gamma, Qiang Liu, Erwan Beauchamp

|Jun 05, 2023
Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study.

Pierre Fenaux, Marco Gobbi, Patricia L Kropf

|Oct 20, 2022
Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial.

Naval G Daver, Monique Dail, Jacqueline S Garcia

|Aug 24, 2021
Improved survival with enasidenib versus standard of care in relapsed/refractory acute myeloid leukemia associated with IDH2 mutations using historical data and propensity score matching analysis.

Stéphane de Botton, Joseph M Brandwein, Andrew H Wei

Pageof 2

Frequent Collaborators

3 joint publications

Gail J Roboz

3 joint publications

Karen Yee

2 joint publications

Tadeusz Robak

2 joint publications

Wieslaw W Jedrzejczak